National Health Investors/$NHI

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About National Health Investors

National Health Investors Inc is a housing and medical facility REIT. The company operates through two reportable segments, i.e., Real Estate Investments and Senior Housing Operating Portfolio (SHOP). The Real Estate Investments segment, which generates maximum revenue, consists of real estate investments and leases, mortgages, and other notes receivables in independent living facilities, assisted living facilities, entrance fee communities, senior living campuses, skilled nursing facilities, and a hospital. The SHOP segment is comprised of two ventures that own the operations of independent living facilities. The company's revenues are derived in the form of rental income, mortgage and other notes receivable interest income, and resident fees and services.

Ticker

$NHI

Primary listing

NYSE

Employees

30

NHI Metrics

BasicAdvanced
$3.7B
24.61
$3.14
0.79
$3.60
4.66%

What the Analysts think about NHI

Analyst ratings (Buy, Hold, Sell) for National Health Investors stock.

Bulls say / Bears say

Net operating income in NHI’s Senior Housing Operating Portfolio (SHOP) climbed 29.4% year-over-year to $3.8 million in Q2 2025, driven by higher occupancy and revenue per room, showcasing strong operational results in its fastest-growing segment (ACCESS Newswire).
As of June 30, 2025, NHI had over $750 million in liquidity and a net debt to adjusted EBITDA ratio of 3.9x, under its 4.0x–5.0x target range, reflecting a solid balance sheet that supports ongoing acquisitions and opportunistic investments (ACCESS Newswire).
NHI's acquisition pipeline remains strong, with about $129.9 million in board-approved LOIs at an 8.0% average initial yield and an additional $343 million in investment opportunities under review, setting the stage for continued accretive growth (ACCESS Newswire).
Activist investor Land & Buildings has launched a proxy fight to replace two board members, citing concerns that NHI’s master lease with its largest tenant, National Healthcare Corp., is below market, highlighting governance and tenant-concentration risks (WSJ).
In Q2 2025, NHI reduced its full-year NAREIT FFO guidance to $4.46–$4.50 per diluted share from $4.64–$4.70, indicating potential margin pressures or slower earnings growth (ACCESS Newswire).
NHI anticipates an $8.8 million reduction in rental income and a $12.1 million non-cash write-off of straight-line rent receivables in Q3 2025, due to transitioning properties leased to Discovery into its SHOP segment, which may temporarily lower cash flows (ACCESS Newswire).
Data summarised monthly by Lightyear AI. Last updated on 2 Oct 2025.

NHI Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

NHI Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $NHI

Sign up or log in to buy
Capital at risk
Market open

Upcoming events

FAQs